B. ARMAĞAN Et Al. , "AB1142 EFFECTS OF SULFASALAZINE USED IN AXIAL SPONDYLOARTHRITIS ON COVID-19 OUTCOMES: REAL-LIFE DATA FROM A SINGLE CENTER," EULAR – Annual European Congress of Rheumatology, 2022 , vol.81, kopenhag, Denmark, pp.1688, 2022
ARMAĞAN, B. Et Al. 2022. AB1142 EFFECTS OF SULFASALAZINE USED IN AXIAL SPONDYLOARTHRITIS ON COVID-19 OUTCOMES: REAL-LIFE DATA FROM A SINGLE CENTER. EULAR – Annual European Congress of Rheumatology, 2022 , (kopenhag, Denmark), 1688.
ARMAĞAN, B., ATALAR, E., GÜVEN, S. C., ÖZDEMİR, B., Konak, H. E., AKYÜZ DAĞLI, P., ... ERDEN, A.(2022). AB1142 EFFECTS OF SULFASALAZINE USED IN AXIAL SPONDYLOARTHRITIS ON COVID-19 OUTCOMES: REAL-LIFE DATA FROM A SINGLE CENTER . EULAR – Annual European Congress of Rheumatology, 2022 (pp.1688). kopenhag, Denmark
ARMAĞAN, BERKAN Et Al. "AB1142 EFFECTS OF SULFASALAZINE USED IN AXIAL SPONDYLOARTHRITIS ON COVID-19 OUTCOMES: REAL-LIFE DATA FROM A SINGLE CENTER," EULAR – Annual European Congress of Rheumatology, 2022, kopenhag, Denmark, 2022
ARMAĞAN, BERKAN Et Al. "AB1142 EFFECTS OF SULFASALAZINE USED IN AXIAL SPONDYLOARTHRITIS ON COVID-19 OUTCOMES: REAL-LIFE DATA FROM A SINGLE CENTER." EULAR – Annual European Congress of Rheumatology, 2022 , kopenhag, Denmark, pp.1688, 2022
ARMAĞAN, B. Et Al. (2022) . "AB1142 EFFECTS OF SULFASALAZINE USED IN AXIAL SPONDYLOARTHRITIS ON COVID-19 OUTCOMES: REAL-LIFE DATA FROM A SINGLE CENTER." EULAR – Annual European Congress of Rheumatology, 2022 , kopenhag, Denmark, p.1688.
@conferencepaper{conferencepaper, author={BERKAN ARMAĞAN Et Al. }, title={AB1142 EFFECTS OF SULFASALAZINE USED IN AXIAL SPONDYLOARTHRITIS ON COVID-19 OUTCOMES: REAL-LIFE DATA FROM A SINGLE CENTER}, congress name={EULAR – Annual European Congress of Rheumatology, 2022}, city={kopenhag}, country={Denmark}, year={2022}, pages={1688} }